AA
FLGT icon

Ancora Advisors’s Fulgent Genetics FLGT Stock Holding History

Ancora Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
500
– – ﹤0.01% 1470
2026
Q1 		$7.95K Sell
500
-7,600
-94% -$165K ﹤0.01% 1837
2025
Q4 		$213K Buy
+8,100
New +$210K ﹤0.01% 725
2023
Q2 		– Sell
-15
Closed -$468 – 1834
2023
Q1 		$468 Buy
+15
New +$483 ﹤0.01% 1735

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ancora Advisors's FLGT Position: Q2 2026 in Review

Ancora Advisors held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 500 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Ancora Advisors first reported a position in FLGT in Q1 2023 and has held it in 4 quarters since. The position peaked at $213K in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Ancora Advisors held 500 shares of Fulgent Genetics worth $10.3K as of Q2 2026.
  • Ancora Advisors left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1470 holding.
  • Ancora Advisors first reported a position in Fulgent Genetics in Q1 2023 and has held it in 4 quarters since.
  • Ancora Advisors's Fulgent Genetics position peaked at $213K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.